Reaction
Hairy Cell Leukaemia Recurrent reporting signals
As of the last recalculation, Hairy Cell Leukaemia Recurrent appears in 40 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is CLADRIBINE (PRR 1,443.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Cladribine | 16 | 1,443.1 | 1,445.5 |
| Vemurafenib | 9 | 502.5 | 502.9 |